Published in J Biol Chem on September 24, 2002
CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol (2009) 2.66
T cell subset-specific susceptibility to aging. Clin Immunol (2008) 2.42
Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther (2003) 1.61
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med (2006) 1.48
The story of CD4+ CD28- T cells revisited: solved or still ongoing? J Immunol Res (2015) 1.47
CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells. J Clin Invest (2003) 1.19
Molecular mechanisms involved in the aging of the T-cell immune response. Curr Genomics (2012) 1.05
Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS One (2011) 0.98
Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss. Osteoporos Int (2011) 0.89
Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis? Arthritis Rheum (2010) 0.89
The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol (2013) 0.85
Expansions of NK-like αβT cells with chronologic aging: novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells. Ageing Res Rev (2010) 0.85
Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics. Scand J Immunol (2014) 0.85
Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy. Arthritis Res Ther (2005) 0.79
Healthy ageing and depletion of intracellular glutathione influences T cell membrane thioredoxin-1 levels and cytokine secretion. Chem Cent J (2013) 0.77
Varying expression of four genes sharing a common regulatory sequence may differentiate rheumatoid arthritis from ageing effects on the CD4(+) lymphocytes. Immunology (2010) 0.76
Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging. Front Immunol (2016) 0.75
Unusual CD4(+)CD28(-) T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders. Immune Netw (2016) 0.75
Phenotypic characteristics of aged CD4(+) CD28(null) T lymphocytes are determined by changes in the whole-genome DNA methylation pattern. Aging Cell (2016) 0.75
The influence of age on T cell generation and TCR diversity. J Immunol (2005) 4.36
Medium- and large-vessel vasculitis. N Engl J Med (2003) 3.96
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med (2007) 3.81
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum (2006) 3.64
Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med (2003) 3.48
Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med (2014) 3.46
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
T cell subset-specific susceptibility to aging. Clin Immunol (2008) 2.42
T cell development and receptor diversity during aging. Curr Opin Immunol (2005) 2.29
The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol (2012) 2.19
Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med (2012) 2.19
Toward plasma proteome profiling with ion mobility-mass spectrometry. J Proteome Res (2006) 2.18
Understanding immunosenescence to improve responses to vaccines. Nat Immunol (2013) 2.09
Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum (2004) 2.08
Aging and T-cell diversity. Exp Gerontol (2007) 2.06
Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med (2013) 1.96
Mapping the human plasma proteome by SCX-LC-IMS-MS. J Am Soc Mass Spectrom (2007) 1.94
Rheumatoid arthritis. Immunol Rev (2005) 1.94
Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation (2008) 1.91
Th17 and Th1 T-cell responses in giant cell arteritis. Circulation (2010) 1.88
Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum (2005) 1.88
Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum (2002) 1.80
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation (2006) 1.77
Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res (2006) 1.77
BLyS and APRIL in rheumatoid arthritis. J Clin Invest (2005) 1.75
Regulation of T cell receptor signaling by activation-induced zinc influx. J Exp Med (2011) 1.73
T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation (2002) 1.72
Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med (2004) 1.70
DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. J Clin Invest (2010) 1.70
Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation (2010) 1.68
Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A (2003) 1.65
T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res (2006) 1.62
Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood (2009) 1.62
Homeostatic control of T-cell generation in neonates. Blood (2003) 1.62
Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther (2003) 1.61
Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest (2015) 1.55
Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci U S A (2009) 1.54
Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med (2009) 1.54
NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs. J Clin Invest (2016) 1.53
Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling. J Biol Chem (2003) 1.51
Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol (2013) 1.48
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med (2006) 1.48
Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation (2007) 1.47
T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med (2004) 1.47
Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol (2006) 1.42
Expression of heat shock protein 72 in peritoneal leukocytes is induced by peritoneal dialysis. Perit Dial Int (2007) 1.42
Rare, structurally homologous self-peptides promote thymocyte positive selection. Immunity (2002) 1.41
Phenotype characterisation using integrated gene transcript, protein and metabolite profiling. Appl Bioinformatics (2004) 1.38
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther (2005) 1.38
T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol (2004) 1.38
Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther (2009) 1.38
Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp Gerontol (2003) 1.38
CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med (2002) 1.38
Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res (2009) 1.37
Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation. Circ Res (2008) 1.35
Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol (2006) 1.34
Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains. J Biol Chem (2001) 1.32
Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.29
Primer on medical genomics. Part XIV: Introduction to systems biology--a new approach to understanding disease and treatment. Mayo Clin Proc (2004) 1.27
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis (2006) 1.26
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol (2011) 1.26
An automated method for the analysis of stable isotope labeling data in proteomics. J Am Soc Mass Spectrom (2005) 1.25
Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum (2008) 1.25
Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol (2008) 1.23